# Osimertinib Plus Durvalumab versus Osimertinib Monotherapy in EGFR T790M–Positive NSCLC following Previous EGFR TKI Therapy: CAURAL Brief Report

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/osimertinib-plus-durvalumab-versus-osimertinib-monotherapy-in-egfr-t790m/

## Facts

| Field | Value |
| --- | --- |
| Author Names | James Chih‐Hsin Yang,Frances A. Shepherd,Dong‐Wan Kim,Gyeong‐Won Lee,Jong Seok Lee,Gee‐Chen Chang,Sung Sook Lee,Yu‐Feng Wei,Yun Gyoo Lee,Gianluca Laus,Barbara Collins,Francesca Pisetzky,Leora Horn |
| Citations | 212 |
| DOI | 10.1016/j.jtho.2019.02.001 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | http://www.jto.org/article/S1556086419301017/pdf |
| OpenAlex ID | https://openalex.org/W2912107322 |
| PMID | 30763730 |
| Type | article |
| Year | 2019 |

## Paper authors

- [James Chih‐Hsin Yang](https://scholariq.org/researchers/james-chih-hsin-yang/)
- [Frances A. Shepherd](https://scholariq.org/researchers/frances-a-shepherd/)
- [Yu‐Feng Wei](https://scholariq.org/researchers/yu-feng-wei/)

## Paper journal

- [Journal of Thoracic Oncology](https://scholariq.org/journals/journal-of-thoracic-oncology/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis](https://scholariq.org/topics/interstitial-lung-diseases-and-idiopathic-pulmonary-fibrosis/)
- [Fibroblast Growth Factor Research](https://scholariq.org/topics/fibroblast-growth-factor-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.